Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Teva
Covington
Colorcon
Fish and Richardson
Cantor Fitzgerald
Express Scripts
Moodys
Federal Trade Commission

Generated: April 19, 2018

DrugPatentWatch Database Preview

DECABID Drug Profile

« Back to Dashboard

Which patents cover Decabid, and what generic alternatives are available?

Decabid is a drug marketed by Lilly and is included in one NDA.

The generic ingredient in DECABID is indecainide hydrochloride. Additional details are available on the indecainide hydrochloride profile page.
Summary for DECABID
US Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: 14
Patent Applications: 131
Drug Prices:see details
DailyMed Link:DECABID at DailyMed
Drug patent expirations by year for DECABID
Synonyms for DECABID
3AZF20DM1T
73681-12-6 (hydrochloride)
74517-78-5
9-(3-((1-methylethyl)amino)propyl)-9H-fluorene-9-carboxamide
9-(3-(Isopropylamino)propyl)-9-fluorenylcarboxamid
9-(3-(Isopropylamino)propyl)-9H-fluorene-9-carboxamide
9-(3-(Isopropylamino)propyl))fluorene-9-carboxamide
9-(3-isopropylaminopropyl)-9-aminocarbonylfluorene
9-[3-(isopropylamino)propyl]fluorene-9-carboxamide
9-[3-(propan-2-ylamino)propyl]fluorene-9-carboxamide
9-{3-[(propan-2-yl)amino]propyl}-9H-fluorene-9-carboxamide
9-carbamoyl-9-(3-isopropylaminopropyl)fluorene
9[3[ amino]propyl]-fluorene-9-carboxamide
9H-Fluorene-9-carboxamide, 9-(3-((1-methylethyl)amino)propyl)-
AC1L1CGM
AK396610
AKOS027381929
AN-5647
C20H24N2O
CAS-74517-78-5
CCRIS 2655
CHEBI:135314
CHEMBL1201242
D0K4CQ
DB00192
Decabid (TN)
DSSTox_CID_31608
DSSTox_GSID_57819
DSSTox_RID_97492
DTXSID2057819
Indecainida
Indecainida [Spanish]
INDECAINIDE
Indecainide [INN]
Indecainidum
Indecainidum [Latin]
LS-177129
LY-135837
NCGC00249887-01
R985
Ricainid
Ricainide
SCHEMBL121202
Tox21_113663
UCEWGESNIULAGX-UHFFFAOYSA-N
UNII-3AZF20DM1T
ZINC1855421

US Patents and Regulatory Information for DECABID

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lilly DECABID indecainide hydrochloride TABLET, EXTENDED RELEASE;ORAL 019693-001 Dec 29, 1989 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Lilly DECABID indecainide hydrochloride TABLET, EXTENDED RELEASE;ORAL 019693-002 Dec 29, 1989 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Lilly DECABID indecainide hydrochloride TABLET, EXTENDED RELEASE;ORAL 019693-003 Dec 29, 1989 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for DECABID

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Lilly DECABID indecainide hydrochloride TABLET, EXTENDED RELEASE;ORAL 019693-001 Dec 29, 1989 ➤ Try a Free Trial ➤ Try a Free Trial
Lilly DECABID indecainide hydrochloride TABLET, EXTENDED RELEASE;ORAL 019693-002 Dec 29, 1989 ➤ Try a Free Trial ➤ Try a Free Trial
Lilly DECABID indecainide hydrochloride TABLET, EXTENDED RELEASE;ORAL 019693-002 Dec 29, 1989 ➤ Try a Free Trial ➤ Try a Free Trial
Lilly DECABID indecainide hydrochloride TABLET, EXTENDED RELEASE;ORAL 019693-001 Dec 29, 1989 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Mallinckrodt
Covington
Fish and Richardson
US Army
Cerilliant
Dow
Fuji
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.